Sentiment · MRK
Lobbying Spend for MRK
AI-generated plain-English read of lobbying spend for MRK. Updated daily.
Heavy lobbying, holding steady
moderateHeavy but steady spend: a well-established government-affairs operation running at cruise control. DC risk is a recurring input to fundamentals for this issuer.
What will probably happen
- Stable spend means no new urgency. Existing policy relationships are being maintained; no imminent legislative inflection is signaled.
- Issue concentration is high (HEALTH ISSUES dominates). The policy outcome of that specific area will drive whether this spend was effective.
What to do
- If you HOLD this stock
- Stable, heavy DC presence is table stakes for this company. No new action triggered. Hold your thesis.
- If you're EVALUATING this stock
- Heavy DC presence is a recurring cost and risk factor. Factor in the regulatory environment when sizing. Requires research into the primary issue areas.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
7 quarters of history with $28.53M total spend: enough for a directional read but trajectory may shift with more data.
Technical details
Technical analysis
- Spend tier
- Heavy
- Trajectory
- Stable
- Last quarter
- $3.10M
- Last 4Q total
- $13.58M
- Prior 4Q total
- $14.95M
- Top issue area
- HEALTH ISSUES (89% of spend)
- Top registrant
- MERCK & CO, INC. (84% of spend)
- Registrant base
- In house
- Quarters on record
- 7
- Unique issue areas
- 12
- Unique registrants
- 15
- Issue concentration
- Laser focused
Key levels
| Level | Value |
|---|---|
| total amount | 28,530,000 |
| last 4q total | 13,580,000 |
| top issue pct | 0.887 |
| prior 4q total | 14,950,000 |
| top registrant pct | 0.842 |
| last quarter amount | 3,100,000 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- A single issue area dominates spend (HEALTH ISSUES, 89%). Read the policy implication of THAT specific issue rather than the aggregate dollar number.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.